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1. Introduction
Cells undergo changes in shape and motile be-
haviour during development and differentiation. These
processes are executed by the cytoskeleton and initi-
ated in response to either external or internal stimuli.
In particular, the microfilament cytoskeleton has been
found a highly sensitive recipient of messages con-
veyed by various signalling cascades, reacting to such
information by either altering the three-dimensional
organisation andror the equilibrium between actin
filaments and a subunit pool. These events have to be
spatially and temporally controlled. One of the most
important proteins that apparently mediates between
signal transduction and the actin cytoskeleton is the
 .small 12–16 kDa actin-binding protein profilin
which has been identified as a protein directly inter-
acting with actin, acidic phospholipids and several
proteins which are members of different signalling
pathways. Although many details of the role of profil-
ins in these processes are still unclear, the data
available today allow for a general concept on how
external messages are sensed by the microfilament
machinery and can thus effect cellular motility and
adhesion.
2. Profilins: genes, products and expression pat-
terns
w xTwo decades ago, Carlsson and co-workers 1
discovered profilin as a G-actin binding protein. Since
then, profilin was identified in all eukaryotes investi-
w x w xgated, such as protozoa 2–4 , echinodermata 5 ,
w x w x w xinsects 6 , plants 7 , and mammals 8,9 . Even a
w xvirus, Vaccinia, contains a profilin gene 10 .
The importance of profilins for cell proliferation
and differentiation was unequivocally demonstrated
in genetic studies. Profilin-deficient mutants of Sac-
charomyces and Dictyostelium are impaired in growth
w xand motility 11–13 , and profilin gene disruption in
Drosophila and mice has been found incompatible
w xwith normal development 14,15 .
Several organisms like maize, Arabidopsis, Acan-
thamoeba, Dictyostelium, Physarum, cow and man
Fig. 1. Comparison of the structural organisation of two distantly related profilins. The X-ray structures of Acanthamoeba profilin I left,
w x.  w x.34 and bovine profilin I right, 31 are shown in similar orientations. The central b-sheets are oriented in parallel to the paper surface
and the N- and C-terminal a-helices are located behind it. While the sequence homology of both proteins is less than 30%, their structural
resemblance is striking. Both molecules comprise 4 a-helices and seven b-strands, which are highly similar in length, position and
orientation.
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w xexpress more than one isoform of profilin 4,16–21 .
In general, the isoforms are products of discrete
genes and differ in their biochemical properties
andror their expression pattern, but in addition, pro-
filin isoforms are created as splice variants, as seen in
w xDrosophila 6,14 .
3. Structural features
All profilins known are defined by common struc-
tural and biochemical properties, although the amino
acid sequences of the corresponding isoforms in dis-
tantly related species may show less than 25% ho-
mology. Three sets of ligands characterise profilins:
w xthey form complexes with G-actin 1,22–24 and
w xactin-related proteins 25 , they bind to polyphospho-
w xinositides 26,27 , and, with the exception of Vac-
 .cinia profilin, they interact with poly-L-proline PLP
w x28–30 , presented either as a peptide or as a se-
quence motif within specific proteins.
Studies on profilins from diverse sources show that
w xthey possess closely related tertiary structures 31–36
 .Fig. 1 . The profilin polypeptide is folded into a
central b-pleated sheet composed of 5–7 antiparallel
b-strands. On one side, this core is flanked by N- and
C-terminal a-helices, with both termini adjacent to
each other, and on the opposite side by a further
a-helix, to which either an additional a-helix or a
 .small b-strand are added Fig. 1 . Similar structures,
which however differ in important details, are dis-
played by other actin-binding proteins like severin
w x w x w x37 , gelsolin 38 and villin 39 .
4. Ligand binding sites on profilin
Although profilin is a relatively small protein, a
number of profilin ligands has already been identified
 .Fig. 2 and the list is still growing. The topography
of the areas involved in ligand binding has been
elucidated by nuclear magnetic resonance spec-
 .troscopy NMR , X-ray crystallography and by bio-
 .chemical studies Fig. 3 .
Profilin binds to G-actin in a 1:1 stoichiometric
complex with an affinity in the micromolar range
 .Table 1 . The participation of the C-terminal a-helix
of profilin in actin-binding had first been detected by
Fig. 2. Schematic view of the main identified profilin ligands.
The arrows point to direct interactions, as determined in in vitro
assays. Note that the location of the actinrpolyphosphoinositide
binding sites is opposite to that of proline-cluster proteins see
.also Fig. 3 , but the exact location of the binding sites for PI
 .3-kinase and annexin I is unknown see text .
chemical cross-linking Lys115 in Acanthamoeba
w xprofilin I to actin Glu364 40 . For bovine profilin I,
w xLys125 seems to occupy a similar position 41 .
Many, but not all profilins, contain the amino acid
motif LADYL in the C-terminal a-helix. Since ho-
mologous sequences had been found in a variety of
actin-binding proteins such as DNase I, fragmin,
gelsolin, severin, villin and the vitamin D-binding
w xprotein 42 , it was suspected that this motif is in-
w xvolved in actin binding 19,33,43 . However, as the
deletion of this motif in Saccharomyces profilin did
w xnot abolish the interaction with actin 44 , and, more-
over, as mammalian profilins lack this sequence, this
hypothesis was abandoned. Today, the LADYL-motif
is considered an element important for the compact
w xstructure of these proteins 34,38,44,45 . In co-crystals
of bovine profilin I and b-actin, the profilin residues
implicated in contacting actin have been localised
within the a-helix 3, the proximal part of a-helix 4,
w x  .and in the b-strands 4, 5 and 6 31 Fig. 3 . These
regions interact with the actin subdomains 1 and 3,
but they do not display a conserved sequence motif
w x35 . The involvement of the actin C-terminus in the
complex formation, revealed by these structural stud-
w xies, confirmed the earlier cross-linking data 40 . In
the bovine complex, Phe375 of the actin partner
seems to play a central role by interacting with Ile73,
w xHis119, Gly121 and Asn124 on the profilin side 31 .
The profilin-actin contact site covers a surface area of
˚
2 w xapproximately 2250 A 31 .
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w xFig. 3. Topographical relation of the main ligand binding domains as seen on the X-ray structure of bovine profilin 31 . The binding
 w x.  w x.domains of actin and actin related proteins blue, 31 and PtdIns 4,5-P red, 50 overlap, while that for proline-cluster sequences2
 w x.green, 56 is located at the opposite site of the profilin molecule.
Table 1
a  .Affinity of profilin isoforms for various ligands expressed as K valuesd
b  .Profilin isoform p I Affinity for actin Affinity for PtdIns 4,5-P Affinity for poly L-proline Refs.2
w xAcanthamoeba IA, B 5.5 7.0 mM 100–500 mM 0.1–0.4 mM 18,59
II G9 9.7 mM 10 mM 0.1 mM
c w xDictyostelium I 6.6 5.1 mM n.d. n.d. 4
II 7.3 1.8 mM n.d. n.d.
w xBirch 5.6 5.0 mM n.d. 0.2 mM 60,134
w xHuman I 8.4 0.6 mM 1 mM similar to II 135
II 5.9 1.3 mM 1 mM similar to I
w xBovine I n.d. 0.3 mM higher than II lower than II 21,49
II n.d. 0.3 mM lower than I higher than I
a The numbers given may not be comparable in each case, since different methods were used in some studies.
b p I, isoelectric point.
c
n.d., not determined.
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In Acanthamoeba, a complex consisting of two
 .actin-related proteins Arp2, Arp3 and of five novel
w xpolypeptides was identified as a profilin ligand 25 .
w xProbably, Arp2 mediates this interaction 46 and
w xuses the same binding site on profilin as actin 47 .
The location of the second important ligand, phos-
 .phatidylinositol 4,5-bisphosphate PtdIns 4,5-P , on2
 .the profilin molecule has also been defined Fig. 3 .
w xThe two profilin isoforms of Acanthamoeba 48 and
w xof mammalian sources 49 differ in their affinity for
 .PtdIns 4,5-P Table 1 . A positively charged region2
opposite to both termini, located within the G-actin
binding site, was postulated as the PtdIns 4,5-P2
w xbinding motif on Acanthamoeba profilin 34 . This
proposal was supported by data obtained with Sac-
charomyces profilin and human profilin I, showing
that point mutations in this area resulted in a de-
w xcreased affinity to PtdIns 4,5-P 44,50 . In accor-2
dance with the view that G-actin and PtdIns 4,5-P2
 .binding sites on profilin overlap Fig. 3 , binding of
these ligands was found to be mutually exclusive
w x26,27,48 . There is also evidence that the interaction
of profilin with PtdIns 4,5-P disrupts the profilin-2
actin complex by inducing a conformational change
w xin profilin 51 .
Recently, the analysis of the interaction of profilin
with different polyphosphoinositides revealed that
human profilin I binds to phosphatidylinositol 3,4-
 .bisphosphate PtdIns 3,4-P and phosphatidylinositol2
 .3,4,5-trisphosphate PtdIns 3,4,5-P with a higher3
w xaffinity than to PtdIns 4,5-P 52 . Furthermore, pro-2
 .filin may regulate phosphoinositide PI 3-kinase ac-
tivity by directly binding to the p85 subunit of this
w xenzyme 53 . PI 3-kinase does not affect the actin-
w xsequestering ability of profilin 53 , indicating that
actin and p85 do not share a common binding site on
profilin.
Several groups have studied the interaction of
 .profilin with the third common ligand, PLP Fig. 2 .
Conveniently, the specificity of this binding is used
for purification of profilins on PLP-affinity columns
w x29,30 . PLP-binding of profilins does not interfere
w xwith binding to G-actin or PtdIns 4,5-P 30,54 ,2
 .inferring a discrete binding site for PLP Fig. 3 . As
seen in Table 1, profilin isoforms may differ in their
w xaffinity for PLP-peptides. By mutant analysis 44,55
w xand NMR 54,56 , the PLP-binding site has been
mapped to a hydrophobic patch involving the NH -2
and COOH-terminal a-helices and the upper face of
the antiparallel b-sheet, opposite to the actinrPtdIns
 .4,5-P binding area Fig. 3 . The extent of this poten-2
tial binding domain suggests that 6 continuous pro-
lines would be sufficient for effectively binding pro-
w xfilin 56 . However, it has been shown that a mini-
mum of 8–10 prolines is necessary for efficient
w xbinding 57–60 . These proline stretches may be in-
w xterrupted by single glycine residues 49,60 and may
be capable of binding two profilins simultaneously
w x49 . Whether the latter finding is in any way related
to the single report on profilin’s capacity to
w xoligomerise 61 , is presently unknown. Although
numerous proteins contain such stretches of ten pro-
lines or longer, the biological significance of the
interaction of profilin with PLP remained an enigma
until the vasodilator-stimulated phosphoprotein
 .VASP was identified as the first ligand for the
w xPLP-binding site 62 . This 46r50-kDa phosphopro-
tein was originally characterised in platelets as a
substrate of both cGMP- and cAMP-dependent pro-
tein kinases, enzymes that are essential for the control
w xof platelet activation 63 . In addition, VASP co-
localises with microfilaments in many different cell
types and there is evidence that it binds directly to
w xF-actin 64,65 . The phosphoprotein VASP is organ-
ised in three distinct domains with a central proline-
 .rich domain, which contains a striking G P motif as5
w xa single copy and as a 3-fold tandem repeat 66 . The
latter is necessary and sufficient for profilin-binding
w x49,60,62 . Recently, Mena, a VASP-related mouse
protein containing similar proline-rich motifs, was
identified as an additional ligand for the PLP-binding
w xsite in profilin 67 .
Furthermore, Saccharomyces cere˝isiae Bni1p and
Bnr1p, Schizosaccharomyces pombe Cdc12p,
Drosophila cappuccino and a novel protein,
p140mDia, the mammalian homologue of the
Drosophila protein diaphanous, were identified as
additional ligands for the proline-cluster binding site
w xon profilins 68–72 . These proteins belong to the
family of formin-related proteins which participate in
cytokinesis, the establishment of cell polarity and
vertebrate limb formation. Formin-related proteins
comprise a proline-rich domain containing several
stretches of 5–13 proline residues and a C-terminal
w xconsensus sequence of about 100 amino acids 73 .
Since Bni1p, Bnr1p and p140mDia also bind with
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high specificity to the GTP-bound form of members
w xof the Rho family 68,72,74 , they probably represent
important links between signal transduction, profilin
and the microfilament system.
Another interesting ligand for the PLP binding site
on profilins maybe the adenylyl cyclase-associated
 .protein CAP . A functional relation between profilin
and CAP was deduced from the fact that overexpres-
sion of profilin can compensate the defects in yeast
w xcells expressing only a truncated CAP 75 . CAP
 .  .contains a G P G P motif and this peptide inter-6 5
w xacts with profilin 49,60 . However, in a number of
assays the intact protein failed to complex with pro-
filin. Apparently, CAP occurs in a folded configura-
w xtion 49 and thus may contain a cryptic, tightly
regulated binding site for profilins.
In addition, human annexin I, which belongs to a
family of Ca2q-dependent phospholipid binding pro-
w xteins 76 , was identified as a ligand for human
w x .profilin I 77 ; Fig. 2 . As annexin I lacks a proline-
rich region, it is probably not a ligand for the PLP-
binding site on profilin. There is evidence that an-
nexin I-binding interferes with the binding of profilin
w xto G-actin and PtdIns 4,5-P 77 , but more informa-2
tion is needed to better define this binding site cf.
.Fig. 3 .
5. Effects of profilins on actin polymerisation in
vitro
After its discovery as a G-actin binding protein,
profilin was considered the key protein in stabilising
w xthe pool of unpolymerised actin in cells 1 . Indeed,
in buffers lacking Mg2q ions, the formation of the
profilin-actin complex alters the G-actinrF-actin ra-
tio and increases the critical concentration for fila-
ment assembly. Addition of profilin to an actin solu-
tion may thus result in filament depolymerisation or
inhibition of actin polymerisation, respectively. How-
ever, it seems that the interaction of profilin with
actin is much more complex than previously be-
lieved. It was shown that profilin inhibits filament
nucleation as well as elongation at the slow growing
 .minus end much more efficiently than at the fast
 . w xgrowing plus end of the actin filament 78–81 . The
profilin-actin complex can be directly added onto the
plus ends of growing filaments and profilin is subse-
w xquently released from these sites 5,81 . Furthermore,
under physiological conditions, the association of the
profilin-actin complex is preferred over the addition
w xof G-actin alone at the plus end 82,83 . Thus, in this
case, profilin lowers the critical concentration for
polymerisation. The presence of other G-actin bind-
ing proteins, such as thymosin b4 or members of the
w xADF family modulates these processes 82 . More-
over, capping the plus end of the filaments prevents
addition of the profilin-actin complexes and thus
reduces profilin’s activity to a mere sequestering
w xeffect 81–83 . Therefore, the effect of profilin on
actin in cells must depend critically on the presence
of other G-actin binding andror capping proteins.
In the past, it has been thought that the ability of
profilins to promote filament assembly at the plus
end is directly linked to their effect on nucleotide
exchange on actin. Filament polymerisation is associ-
ated with the hydrolysis of the actin-bound ATP and
so far, profilins are the only microfilament associated
proteins known which can act as nucleotide exchange
factors. ATP-actin polymerises faster and at a lower
w xcritical concentration than ADP-actin 84 . However,
Arabidopsis profilin isoforms I and III apparently fail
to accelerate the rate of nucleotide exchange on
G-actin but still decrease the critical concentration at
the plus ends of filaments, like vertebrate profilin
w x83 . These findings implicate that the prime effect of
profilins on actin polymerisation cannot be associated
with their ability to act as nucleotide exchange fac-
tors.
6. Intracellular localisation of profilins
The in vitro studies described above suggest that
the interaction between profilins and actin in cells is
highly complex, but from all these data one might
expect that profilins should be concentrated in cyto-
plasmic areas with rapidly growing and highly dy-
namic actin filaments. However, the respective locali-
sation studies were not unequivocally accepted, first,
because it is difficult to raise good profilin antibod-
ies, and second, because the high solubility of pro-
filin was considered a serious obstacle. This latter
argument seems not as relevant as previously be-
lieved, as it has been shown that little profilin is lost
w xfrom fixed, extracted cells 85 , possibly because
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profilins are bound to larger ligand proteins see
.Section 3 .
In Acanthamoeba, Schizosaccharomyces, loco-
moting and spreading mammalian cells, profilin was
indeed seen concentrated in areas of highly dynamic
microfilaments, such as the cell cortex, filopodia,
nascent focal contacts and the ruffling membrane at
w xthe leading edge 25,85–89 . Microinjected profilin
and fluorescent derivatives targeted to the same sites
w x85,89,90 . Conversely, profilin was not seen en-
riched at more stable microfilament aggregates, such
as stress fibres and peripheral belts in stationary
w xtissue culture cells 87,89 . In contrast to these data,
the profilin distribution in lily pollen tubes was found
to be homogeneous and not associated with either the
w xplasma membrane or actin filaments 91 . In Tetrahy-
mena, profilin was seen concentrated in the cleavage
w xfurrow 92 , while in epithelial cells, the profilin level
in the cleavage furrow was found conspicuously low
w x89 .
In human platelets and leukocytes, profilin was
also found enriched in areas of the plasma membrane
seemingly devoid of actin filaments. It was specu-
lated that in this case, profilin was membrane bound
w xvia PtdIns 4,5-P 93 . In Saccharomyces, there is2
apparently a correlation between the phosphoinositide
metabolism and membrane localisation of profilin:
under growth conditions, when plasma membrane
levels of PtdIns 4,5-P are low, a translocation of2
profilin occurred from the plasma membrane to the
w xcytosolic fraction 94 .
Double immunofluorescence was employed to
demonstrate the co-localisation of profilin with its
w x w xligands VASP 62 and p140mDia 72 in mammalian
cells, and with the actin-related proteins Arp2 and
w xArp3 in Acanthamoeba 25 , supporting the view that
the interaction of profilin with these ligands seen in
vitro is also relevant in cells.
7. The effect of profilin on microfilament organi-
sation in vivo
As mentioned above, for many years the main
biological function of profilin was seen in its actin
sequestering effect. Meanwhile, this global view is
questionable, mainly due to the fact that the cellular
concentration of profilin and its affinity to actin is
w xinsufficient to stabilise the G-actin pool 57,80,95,96 .
By and large, the results obtained with cells display-
ing altered profilin levels are consistent with the
concept that in lower eukaryotes the main role of
profilin is indeed to sequester G-actin, while in higher
eukaryotes this function is mainly executed by other
w xG-actin binding proteins like thymosin b4 97 , and
profilins are primarily involved in the regulation of
w xactin filament dynamics 96 . Hence, a decrease or
deficiency of profilins in lower eukaryotes should
result in an increase of F-actin, while this would not
be the prime effect in higher eukaryotes.
Data consistent with this model comprise the fol-
lowing. S. pombe cells which overproduce profilin
become elongated, dumbbell-shaped, and arrested in
cytokinesis. These cells lack detectable actin fila-
w xments, and are unable to form a contractile ring 88 .
The deleterious effects of actin overexpression in S.
cere˝isiae cells could be compensated by an overex-
w xpression of profilin 98 . Conversely, a 70% increase
in F-actin concentration was observed in Dic-
tyostelium mutants lacking both profilin isoforms,
concomitant with a reduction in motility, an increase
in size and a defect in cytokinesis. Development was
w xblocked prior to fruiting body formation 13 . Similar
defects were found in profilin-deficient S. cere˝isiae
w xcells 12 .
In contrast, a significant body of data points to a
filament-stabilising or -regulating function of profilin
 .in higher eukaryotes. In CHO chinese hamster ovary
cells overexpressing profilin, a significant proportion
of F-actin was shifted from stress fibres to the corti-
cal actin network, while the overall F-actin content
w xand stability was increased 99 . Similarly, in BHK
 .baby hamster kidney cells overexpressing birch pro-
filin, actin filaments were stabilised against cyto-
w xchalasin D and latrunculin 85 . Cultured human en-
dothelial cells overexpressing profilin 32-fold dis-
played a shift in F-actin from stress fibres to thick
peripheral actin filament bundles with a correspond-
w xing increase in cellular adhesion to fibronectin 100 .
Drosophila mutants deficient in the ovary-specific
profilin are not viable, probably because actin fila-
ment bundles are absent in nurse cells, which pre-
w xvents nutrient transport to the oocyte 6,14 . Addi-
tionally, the localisation of specific mRNAs to the
posterior pole of developing Drosophila oocytes was
w xabnormal 71 . In vertebrates, lack of profilin I is
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apparently lethal, as developing embryos of a profilin
I knock-out mouse die before reaching the 64 cell
w xstage 15 .
While these data support a differential role of
profilins between lower and higher eukaryotes, there
are a few studies which seem to contradict these
reports. In contrast to what might have been expected
for overexpressing Drosophila profilin in S. pombe,
these cells showed an increase, not a decrease in the
w xF-actin content 101 . This might be the consequence
of introducing a profilin from a higher eukaryote into
the environment of a lower eukaryote cytoplasm. In
addition, all microinjection experiments in higher
eukaryotes seemingly do not fit the hypothesis. Mi-
croinjection of birch profilin in Tradescantia stamen
hair cells led to a rapid depolymerisation of single
w xactin filaments 102 . In microinjected rat fibroblasts,
profilin caused disruption of cortical actin filaments
and stress fibres, while focal adhesion sites and con-
w xtractile rings were not effected 103 . Possibly, a
drastic local increase of the profilin level induced by
microinjection might attack actin filaments in such
cells, while transfection and overexpression result in
stabilisation and even increase in F-actin. Thus, a
final judgement on the validity of the hypothesis
concerning differential functions of profilins in higher
and lower eukaryotes must await further experimental
data.
Analysis of mutants revealed that profilins are
essential for cytokinesis, since all profilin null mu-
tants known of Dictyostelium, Saccharomyces or
w xDrosophila developed multinucleated cells 12–14 .
In Schizosaccharomyces, overexpression as well as
deficiency of profilin led to defects in cytokinesis
w x88,104 . These findings do of course not demand the
presence of profilins exactly at the site of the cleav-
age furrow. The conflicting reports on profilin’s pres-
ence in this area have already been mentioned.
Differential expression patterns point to specific
functions of profilin isoforms in microfilament organ-
isation. In some organisms, the expression levels of
profilin and particular isoforms depend on the devel-
opmental stage. Sea urchins start to express a devel-
opmental-specific profilin isoform at the beginning of
gastrulation — a highly dynamic process, in which
w xthe cytoskeleton is totally reorganised 105 . In
Drosophila ontogenesis, the expression level of pro-
filin is again high during gastrulation, which in insect
eggs is also characterised by a highly dynamic micro-
w xfilament system 14 . As mentioned above, the ex-
pression of different profilin isoforms in lower eu-
w xkaryotes like Physarum or Dictyostelium 4,19 is
correlated with the stage in the life cycle. In mam-
mals, the amount of profilin I varies considerably in
w xdifferent tissues 106 . Moreover, the ratio of profilin
I to II can vary, e.g. in human and bovine brain, there
is much more profilin II than profilin I, whereas in
w xliver and spleen the proportions are reversed 20,21 .
8. The role of profilin in signal transduction
The original finding of profilins binding to actin as
well as to signalling polyphosphoinositides created
the concept of profilin mediating between PtdIns
4,5-P signalling and the regulation of the microfila-2
w xment system 57,96 . Today, this model still holds,
but it apparently is only a small piece in a much
larger puzzle. As described in Section 3, there is a
growing list of profilin ligands, many of them for the
PLP-binding site, which are members of various sig-
nal transduction pathways. This allows for a scheme
as depicted in Fig. 4, showing the multitude of
interactions between profilin, the microfilament sys-
tem and different signalling routes.
The binding of profilins to PtdIns 4,5-P links2
them to the phosphatidylinositol cycle and in this
way to the receptor tyrosine kinase pathway. PtdIns
4,5-P bound to profilin is protected against hydroly-2
w xsis by phospholipase Cg1 107 , but phosphorylation
of the phospholipase by receptor tyrosine kinases
w xovercomes this inhibition 108 . In contrast to PtdIns
4,5-P , the two products of the PI 3-kinase activity,2
PtdIns 3,4-P and PtdIns 3,4,5-P , which bind to2 3
profilin with a higher affinity than PtdIns 4,5-P , are2
resistant against hydrolysis by activated phospholi-
pase Cg1. These results have led to the view that
phosphatidylinositol 3,4-bisphosphate and phos-
phatidylinositol 3,4,5-trisphosphate may regulate
phospholipase Cg1-controlled PtdIns 4,5-P turnover2
w x52 . Hydrolysis of PtdIns 4,5-P by phospholipase2
Cg1 yields two second messengers, diacylglycerol
and inositol 1,4,5-trisphosphate and releases profilin
from the membrane, which might lead to rapid, local
actin polymerisation as observed after stimulation of
cells with growth factors.
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 .Fig. 4. The involvement of profilin red in different signalling routes. This schematic drawing depicts only the main connections
 .established so far see Section 7 for explanation . Molecules and second messengers of the polyphosphoinositide signalling pathway are
indicated in yellow, protein members of signalling routes are marked green, proline-cluster proteins identified as profilin ligands are
marked purple, the actin cycle is seen in blue, Ca2q in intracellular stores and Ca2q regulated microfilament proteins are marked grey.
For simplicity, the solid arrows indicate either direct interactions between components, as shown by biochemical assays, or point to
pathways. Broken arrows indicate suspected or indirect interactions. Abbreviations: PI-3,4,5-P : phosphatidylinositol 3,4,5-trisphosphate;3
PIP : phosphatidylinositol 4,5-bisphosphate; RTK: receptor tyrosine kinase; DAG: diacylglycerol; PLCg1: phospholipase Cg1; cAMP-2
rcGMP-PK: cAMPrcGMP dependent protein kinase; IP : inositol 1,4,5-trisphosphate.3
 .The formin-related profilin ligands see Section 3 ,
of which p140mDia is depicted as the mammalian
representative in Fig. 4, connect the microfilament
system with the GTPase-related signalling cascade,
which is also linked to the PtdIns 4,5-P signalling2
pathway. The small GTPases of the Rho family are
actively engaged in the regulation of microfilament-
based processes such as cell morphology, adhesion
w xand cytokinesis 109 . The formin-related proteins are
probably down-stream effectors of Rho in this cas-
w xcade 68,72 .
On the other hand, proteins of the VASPrMena
family, which are substrates for the cAMPrcGMP-
w xdependent protein kinases 67,110 and the suspected
profilin ligand CAP, which activates the adenylyl
w xcyclase 111–113 , tie the microfilament system to
the adenylyl cyclase-related pathway, even by two
strings. First, CAP and the VASP proteins may bind
w xdirectly to actin 64,114–117 . Second, the VASP
proteins might recruit profilin and profilin-actin com-
plexes to regions of dynamic actin remodelling by
binding to cell contact proteins such as zyxin and
w xvinculin 67,118–120 .
The involvement of annexin I in this interplay
could be envisioned in the reported sensitivity of
annexin I-profilin interaction to PtdIns 4,5-P and2
w xactin 77 as well as in the fact that the activity of
annexins is regulated by the free Ca2q level, which is
modulated by PtdIns 4,5-P cleavage achieved by the2
 .activated phospholipase Cg1 Fig. 4 . In turn, changes
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in the Ca2q level will affect not only annexin I, but
also a number of Ca2q-actin-binding and -severing
proteins which fragment actin filaments and generate
new plus ends for the addition of profilin-actin com-
 .plexes Fig. 4 .
9. Biomedical aspects
From knock-out mutants of profilins, such as gen-
erated in mice, Dictyostelium and yeast see Section
.6 , it became evident that profilins are essential com-
ponents of the microfilament system. In addition,
there are cellular conditions of biomedical interest
which emphasise the importance of profilins in all
microfilament-based processes. Three different sce-
narios shall be mentioned in this context.
The microfilament system determines shape, adhe-
sion and locomotion of epithelial cells and in many
cancer cells, especially in those with a high metastatic
capacity, these processes are abnormal. In particular,
cell adhesion may be decreased, while locomotory
activity is increased. As these processes involve the
extracellular matrix, the transmembrane proteins of
junctional complexes and the tightly regulated inter-
play of microfilament components, there may of
course be many reasons for such abnormalities, but
there is now evidence that at least in some instances,
the pathological condition is correlated with an ab-
normal profilin level. Thus, the expression level of
profilin in human gastric cancer was found to be
w xsignificantly higher than in normal gastric tissue 121 .
Whether this finding is causally related to a higher
mobility of the gastric cells is unknown so far.
A second medical problem in which profilins may
play an important role comprises the lateral spreading
of some infectious diseases through tissues. Subse-
quent to entering the intestinal epithelial cell layer,
several intracellular pathogens like Listeria monocy-
togenes and Shigella flexneri usurp the host cell’s
microfilament system and construct actin filament
‘comet tails’ at one pole of each bacterial cell
w x122,123 . These elements are vital for intracellular
motility and for cell-to-cell spreading of the pathogen.
In composition and arrangement, the comet tails of
Listeria resemble remarkably the distal ends of mi-
crofilament bundles in normal, uninfected cells, at
plasma membrane attachment sites. Although the ex-
act role of profilin in this process is not yet under-
stood, it is thought that it may deliver G-actin sub-
units to the bacterial surface in the form of profilin-
 w x.actin complexes cf. 123 , which may be concen-
trated in this position by VASP or related proteins
w x122,124–126 . At present, there are conflicting data
on the precise role of profilins in these processes. It
may be that profilin is not absolutely required for
w xbacterial motility 127,128 , but optimises its effi-
ciency — a parameter which should be very impor-
tant in the battle between the host’s immune system
and the pathogen. Notably, neither profilins nor the
VASP proteins could act as transmitters of external
signals at the bacterial surface, as motile bacteria are
observed in the cytosol, without contact to the plasma
membrane. In this position, the function of profilin in
microfilament dynamics and organisation must be
prevalent.
Furthermore, profilins gained medical attention in
quite another, unexpected context. It turned out that
profilins are involved in generating type I allergies,
which cause rhinitis, conjunctivitis, and asthma in
afflicted persons and which show an increasing fre-
quency in industrialised countries. Profilins were
identified as major allergens, responsible for pollen
and food allergies in about 20% of patients suffering
w xfrom type I allergies 129–131 . Profilin-specific pa-
tient IgEs cross-react with human profilin and indi-
viduals hypersensitive to plant profilins show allergic
reactions to human profilin, suggesting that an au-
toimmune reaction may maintain continued sensitisa-
w xtion even in the absence of plant profilins 129 .
Hence, specific, epitope-designed antibodies against
profilin may be valuable tools in diagnosis, and
eventually also in therapy of this type of allergies.
10. Conclusions
w xSince the discovery of profilin in 1977 1 , cell
biologists have collected a wealth of information on
structure and presumed function, but many important
questions remain open. What is the exact function of
the different isoforms? Why do plants express more
isoforms than animals or protozoa, and is this corre-
lated with the fact that plants also express many actin
w xisoforms 132 ? What precisely is the role of profilin
in actin dynamics in the different organisms, and
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what is its role in the different signal transduction
pathways? Is there competition for the PLP-binding
site of the different proline-cluster proteins? How
might such a competition be regulated, and what
consequences would it have for a particular signalling
route?
Progress in answering at least a few of these
questions can be expected in the future mainly from
two sets of experiments. First, genetic studies with
conditional knock-out mutants should allow to under-
stand the function of different isoforms in different
tissues in the organism. Second, the multitude of
interactions of profilins with microfilament and sig-
nalling molecules must be probed in cells. Only when
we learn more about the spatial and temporal regula-
tion of the formation, selection and stability of such
complexes in the living cell can we hope to under-
stand such puzzling schemes as depicted in Fig. 4.
The recent improvement of the technique of fluores-
cence energy transfer, using proteins tagged with
different green fluorescent protein constructs in con-
junction with confocal laser scanning microscopy, is
w xan encouraging approach to this problem 133 .
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